Log In
BCIQ
Print this Print this
 

Davictrel, biosimilar etanercept (HD203)

  Manage Alerts
Collapse Summary General Information
Company Hanwha Chemical Corp.
DescriptionBiosimilar of etanercept
Molecular Target Tumor necrosis factor (TNF) alpha ; Lymphotoxin alpha
Mechanism of ActionTumor necrosis factor (TNF) alpha inhibitor; Biosimilar
Therapeutic ModalityBiologic: Protein
Latest Stage of DevelopmentMarketed
Standard IndicationRheumatoid arthritis (RA)
Indication DetailsTreat rheumatoid arthritis (RA)
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

06/13/2011

Undisclosed

Undisclosed

Undisclosed

Get a free BioCentury trial today